Literature DB >> 21487424

Infectious disease: CXCL13 is a potential biomarker for Lyme neuroborreliosis.

Katie Kingwell.   

Abstract

Entities:  

Year:  2011        PMID： 21487424     DOI： 10.1038/nrneurol.2011.50

Source DB:  PubMed          Journal:  Nat Rev Neurol        ISSN： 1759-4758            Impact factor:   42.937


× No keyword cloud information.
  1 in total

1.  A prospective study on the role of CXCL13 in Lyme neuroborreliosis.

Authors:  C Schmidt; A Plate; B Angele; H-W Pfister; M Wick; U Koedel; T A Rupprecht
Journal:  Neurology       Date:  2011-03-22       Impact factor: 9.910
  1 in total
  5 in total

1.  Comparative Analysis of the Euroimmun CXCL13 Enzyme-Linked Immunosorbent Assay and the ReaScan Lateral Flow Immunoassay for Diagnosis of Lyme Neuroborreliosis.

Authors:  Jörg Steinmann; Jürgen Held; Katharina Ziegler; Anca Rath; Christoph Schoerner; Renate Meyer; Thomas Bertsch; Frank Erbguth; Christian Bogdan
Journal:  J Clin Microbiol       Date:  2020-08-24       Impact factor: 5.948

2.  A case of relapsing-remitting neuroborreliosis? Challenges in the differential diagnosis of recurrent myelitis.

Authors:  P Albrecht; N Henke; H C Lehmann; S Macht; H Hefter; N Goebels; C Mackenzie; T A Rupprecht; V Fingerle; H P Hartung; A Methner
Journal:  Case Rep Neurol       Date:  2012-03-14

3.  Multi-marker algorithms based on CXCL13, IL-10, sIL-2 receptor, and β2-microglobulin in cerebrospinal fluid to diagnose CNS lymphoma.

Authors:  Masahiro Maeyama; Takashi Sasayama; Kazuhiro Tanaka; Satoshi Nakamizo; Hirotomo Tanaka; Masamitsu Nishihara; Yuichi Fujita; Kenji Sekiguchi; Masaaki Kohta; Katsu Mizukawa; Takanori Hirose; Tomoo Itoh; Eiji Kohmura
Journal:  Cancer Med       Date:  2020-04-20       Impact factor: 4.452

4.  Comparative proteomics profiling revealed the involvement of GRB2-ROCK2 axis in Lyme neuroborreliosis caused by Borrelia Burgdorferi.

Authors:  Yunfeng Bi; Jianjun Liu; Mingbiao Ma; Lvyan Tao; Yun Peng; Xiting Dai; Zhenhua Ji; Ruolan Bai; Miaomiao Jian; Taigui Chen; Lisha Luo; Feng Wang; Zhe Ding; Aihua Liu; Fukai Bao
Journal:  J Cell Mol Med       Date:  2022-02-25       Impact factor: 5.295

5.  CXCL13 may improve diagnosis in early neuroborreliosis with atypical laboratory findings.

Authors:  Johannes P Borde; Simone Meier; Volker Fingerle; Christiane Klier; Johannes Hübner; Winfried V Kern
Journal:  BMC Infect Dis       Date:  2012-12-10       Impact factor: 3.090
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.